1. A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic. (June 2021) Authors: Church, Matt; Taylor, Paul; Summers, Yvonne; Califano, Raffaele; Rafee, Shereen; Dixon, Mairead; Clarke, Lisa; Cove-Smith, Laura Journal: Lung cancer Issue: Volume 156(2021)Supplement 1 Page Start: S31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Neoadjuvant Crizotinib in Advanced Inflammatory Myofibroblastic Tumour with ALK Gene Rearrangement. Issue 2 (March 2015) Authors: Rafee, Shereen; Elamin, Yasir Y.; Joyce, Eimear; Toner, Mary; Flavin, Richard; McDermott, Ronan; Sheehy, Niall; Hennessy, Bryan; O'Byrne, Kenneth; Gleeson, Noreen; Osman, Nemer Journal: Tumori Issue: Volume 101:Issue 2(2015) Page Start: e35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Real-world use of different pembrolizumab regimens (3 weekly versus 6 weekly) in non-small cell lung cancer (NSCLC) patients. (March 2022) Authors: Osborne, Lucy; Ortega-Franco, Ana; Hodgson, Clare; Pearce, Mark; Moss, Anna; Lindsay, Colin; Hughes, Sarah; Taylor, Paul; Califano, Raffaele; Rafee, Shereen; Gomes, Fabio; Summers, Yvonne; Blackhall, Fiona; Cove-Smith, Laura; Halkyard, Emma; Fenemore, Jackie Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Targeting the fibroblast growth factor receptor family in cancer. (May 2016) Authors: Hallinan, Niamh; Finn, Stephen; Cuffe, Sinead; Rafee, Shereen; O'Byrne, Kenneth; Gately, Kathy Journal: Cancer treatment reviews Issue: Volume 46(2016) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗